Basilea-Logo.jpg
Basilea initiates clinical phase 3 study with antifungal fosmanogepix in candidemia and invasive candidiasis
September 24, 2024 01:15 ET | Basilea Pharmaceutica AG, Allschwil
Allschwil, Switzerland, September 24, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe...
Santhera gibt Annahm
Santhera gibt Annahme des Zulassungsantrags für AGAMREE® (Vamorolon) bei Duchenne-Muskeldystrophie durch Swissmedic bekannt
September 24, 2024 01:00 ET | Santhera Pharmaceuticals Holding AG
Pratteln, Schweiz, 24. September 2024 – Santhera Pharmaceuticals (SIX: SANN) gibt bekannt, dass das Schweizerische Heilmittelinstitut Swissmedic das Zulassungsgesuch (marketing authorization...
Santhera Announces A
Santhera Announces Acceptance by Swissmedic of Marketing Authorization Application for AGAMREE® (vamorolone) in Duchenne Muscular Dystrophy
September 24, 2024 01:00 ET | Santhera Pharmaceuticals Holding AG
Pratteln, Switzerland, September 24, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces that Swissmedic, the Swiss Agency for Therapeutic Products, has accepted for review the marketing...
WISeKey Logo.png
WISeKey Announces OISTE’s Participation at the Summit of the Future
September 23, 2024 17:41 ET | Wisekey International Holding Ltd.
WISeKey Announces OISTE’s Participation at the Summit of the Future New York, New York - September 23, 2024: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY),...
21shares_B_Logotype_Marigold_Digital.png
21.co Integrates Chainlink Proof of Reserve To Increase Transparency of its Wrapped Bitcoin (21BTC) on Solana and Ethereum
September 23, 2024 12:00 ET | 21Shares
ZURICH, 23 September 2024 – 21.co, the parent company of 21Shares – one of the world’s largest issuers of crypto exchange traded products (ETPs), today announced the integration of the...
roche-logo-blue.png
WHO endorses dual-stain cytology (CINtec PLUS) testing in its cervical cancer prevention guidelines, advancing patient care and underlining Roche’s role in pioneering cervical cancer solutions
September 23, 2024 01:00 ET | F. Hoffmann-La Roche Ltd
Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results Dual-stain biomarkers aid in...